Syndax Pharmaceuticals, Inc. (SNDX) is a publicly traded Healthcare sector company. As of May 21, 2026, SNDX trades at $20.23 with a market cap of $1.72B and a P/E ratio of -6.10. SNDX moved +4.08% today. Year to date, SNDX is -0.45%; over the trailing twelve months it is +90.44%. Its 52-week range spans $8.58 to $25.59. Analyst consensus is strong buy with an average price target of $39.91. Rallies surfaces SNDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What are SNDX's key financials?
SNDX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SNDX recently traded at $20.23. Market cap is $1.72B. P/E ratio is -6.10. Revenue is $172.35M.
SNDX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SNDX recently traded at $20.23. Market cap is $1.72B. P/E ratio is -6.10. Revenue is $172.35M.
Is SNDX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SNDX. It does not provide personalized investment advice.
